BBNX
Beta BionicsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BBNX
Beta Bionics, Inc.
A commercialized medical device company
Healthcare Equipment and Supplies
10/21/2015
01/30/2025
NASDAQ Stock Exchange
291
12-31
Common stock
11 Hughes, Irvine, California 92618
--
Beta Bionics, Inc., was incorporated as a Massachusetts welfare corporation on October 21, 2015 and converted to a Delaware corporation in August 2024. The Company is a commercial-stage medical device company engaged in the design, development and commercialization of innovative solutions to improve the health and quality of life of diabetic patients with insulin needs by leveraging advanced adaptive closed-loop algorithms to simplify and improve the treatment of their diseases.
Company Financials
EPS
BBNX has released its 2025 Q3 earnings. EPS was reported at -0.33, versus the expected -0.41, beating expectations. The chart below visualizes how BBNX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BBNX has released its 2025 Q3 earnings report, with revenue of 27.25M, reflecting a YoY change of 63.14%, and net profit of -14.21M, showing a YoY change of -45.94%. The Sankey diagram below clearly presents BBNX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
